# Dongguan Punuokang Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dongguan-punuokang-biotechnology-co

- Headquarters: Dongguan, China
- Latest round: Seed (Jul 29, 2025)
- Investors on record: 1

## About

Founded in 2025 and based in China, Guangdong, Dongguan Punuokang Biotechnology Co., Ltd. operates as a developer of innovative drugs for pet metabolic diseases, focusing on the research, development, and commercialization of innovative therapies for metabolic diseases such as heart disease, cancer, and kidney disease. The company is a developer of innovative drugs for pet diseases. In February 2026, Dongguan Punuokang Biotechnology Co., Ltd. raised a venture funding from Dongguan Kechuang Capital.
The company has established a highly skilled R&D team and an independent R&D system and focuses on the research and development of innovative drugs for pet metabolic diseases, focusing on areas such as heart disease, oncology, and kidney disease. The company's revenue is generated by researching and providing pet pharmaceutical products.

## Funding rounds

- Seed, Jul 29, 2025 — Triwise Capital

## Investors

- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Seed